Contrary to the tumor-suppressive role of TGF-β at early tumor development stages, malignant cells at late stages downregulate expression of TGF-β receptors and become resistant to TGF-β-mediated growth inhibition. This evidence concerns the gene TGFB1 and neoplasm.